Experimental neurology · 2025
Experimental and computational study of 40 Hz low-field magnetic stimulation modulating neural activity and pathology in a mouse model of Alzheimer's disease.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Geng Duyan, Yan Yuxin, Liu Aoge, Zheng Weiran
Аннотация
BACKGROUND: Low-field magnetic stimulation (LFMS) is a non-invasive, subthreshold neuromodulation technique that has demonstrated rapid mood-enhancing effects in depression. Given that depression often presents as an early symptom of Alzheimer's disease (AD), and both conditions are classified as neuropsychiatric disorders, the potential of LFMS as an intervention for AD and its underlying mechanisms remains underexplored.
METHODS: This study employed a randomized controlled design using 7-month-old APP/PS1 transgenic Alzheimer's disease mice and C57BL/6 J wild-type mice. The stimulation group received low-field magnetic stimulation at 40 Hz and 10 mT twice daily for 0.5 h each session, while the sham group was exposed to the same conditions without activation. The intervention lasted for 14 consecutive days. Electrophysiological activity and Aβ42 deposition were assessed via local field potential recordings and immunofluorescence. Additionally, finite element simulations and computational neural network modeling were performed to analyze the relationship between LFMS-induced electric fields and neuronal responses.
RESULTS: The results showed that 40 Hz LFMS significantly enhanced gamma oscillations during sharp-wave ripples in the AD mouse model and reduced hippocampal Aβ42 deposition by 2.7 %. Finite element simulations indicated that under experimental conditions, LFMS induced a peak electric field of approximately 0.3 V/m in the mouse brain. Computational modeling further demonstrated that this subthreshold pulsed electric field modulated neuronal spike timing, increasing the phase-locking value by 0.044, thereby regulating neuronal activity.
CONCLUSION: 40 Hz LFMS entrained endogenous gamma oscillations, significantly enhanced gamma power and reduced Aβ42 pathological deposition, offering a safe and effective neuromodulation strategy for Alzheimer's disease.
METHODS: This study employed a randomized controlled design using 7-month-old APP/PS1 transgenic Alzheimer's disease mice and C57BL/6 J wild-type mice. The stimulation group received low-field magnetic stimulation at 40 Hz and 10 mT twice daily for 0.5 h each session, while the sham group was exposed to the same conditions without activation. The intervention lasted for 14 consecutive days. Electrophysiological activity and Aβ42 deposition were assessed via local field potential recordings and immunofluorescence. Additionally, finite element simulations and computational neural network modeling were performed to analyze the relationship between LFMS-induced electric fields and neuronal responses.
RESULTS: The results showed that 40 Hz LFMS significantly enhanced gamma oscillations during sharp-wave ripples in the AD mouse model and reduced hippocampal Aβ42 deposition by 2.7 %. Finite element simulations indicated that under experimental conditions, LFMS induced a peak electric field of approximately 0.3 V/m in the mouse brain. Computational modeling further demonstrated that this subthreshold pulsed electric field modulated neuronal spike timing, increasing the phase-locking value by 0.044, thereby regulating neuronal activity.
CONCLUSION: 40 Hz LFMS entrained endogenous gamma oscillations, significantly enhanced gamma power and reduced Aβ42 pathological deposition, offering a safe and effective neuromodulation strategy for Alzheimer's disease.